SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $120 | -100.0% | 2,562 | -85.2% | 0.00% | -100.0% |
| Q2 2022 | $559,000 | -22.9% | 17,320 | -21.0% | 0.00% | 0.0% |
| Q1 2022 | $725,000 | +194.7% | 21,929 | +279.2% | 0.00% | – |
| Q4 2021 | $246,000 | -66.2% | 5,783 | -54.4% | 0.00% | -100.0% |
| Q3 2021 | $727,000 | +1.1% | 12,679 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $719,000 | -72.9% | 12,671 | -64.3% | 0.00% | -80.0% |
| Q1 2021 | $2,655,000 | +727.1% | 35,473 | +853.1% | 0.01% | – |
| Q4 2020 | $321,000 | +386.4% | 3,722 | +239.9% | 0.00% | – |
| Q3 2020 | $66,000 | -78.6% | 1,095 | -89.8% | 0.00% | -100.0% |
| Q1 2020 | $309,000 | -39.3% | 10,779 | +196.8% | 0.00% | 0.0% |
| Q3 2019 | $509,000 | +25.4% | 3,632 | +63.8% | 0.00% | 0.0% |
| Q2 2019 | $406,000 | +15.3% | 2,218 | -11.2% | 0.00% | 0.0% |
| Q3 2018 | $352,000 | -38.5% | 2,499 | -31.6% | 0.00% | -50.0% |
| Q2 2018 | $572,000 | +1000.0% | 3,655 | +1031.6% | 0.00% | 0.0% |
| Q1 2018 | $52,000 | -72.8% | 323 | -72.2% | 0.00% | -75.0% |
| Q4 2017 | $191,000 | -86.0% | 1,161 | -94.7% | 0.01% | -85.7% |
| Q3 2017 | $1,366,000 | +85.3% | 21,938 | +137.0% | 0.06% | +75.0% |
| Q2 2017 | $737,000 | +622.5% | 9,258 | +540.2% | 0.03% | +700.0% |
| Q1 2017 | $102,000 | -20.3% | 1,446 | -42.7% | 0.00% | -50.0% |
| Q4 2016 | $128,000 | -6.6% | 2,523 | -15.4% | 0.01% | -11.1% |
| Q3 2016 | $137,000 | -83.7% | 2,984 | -89.3% | 0.01% | -83.9% |
| Q2 2016 | $842,000 | +308.7% | 27,970 | +471.9% | 0.06% | +273.3% |
| Q3 2015 | $206,000 | +8.4% | 4,891 | +87.7% | 0.02% | -6.2% |
| Q2 2015 | $190,000 | – | 2,606 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |